IBRX•benzinga•
Piper Sandler Upgrades ImmunityBio to Overweight, Raises Price Target to $5
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2025 by benzinga